See more : HELLA GmbH & Co. KGaA (HLLGY) Income Statement Analysis – Financial Results
Complete financial analysis of Acadia Healthcare Company, Inc. (ACHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Acadia Healthcare Company, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Advantech Co., Ltd. (2395.TW) Income Statement Analysis – Financial Results
- Sibanye Stillwater Limited (SSW.JO) Income Statement Analysis – Financial Results
- Ruchi Infrastructure Limited (RUCHINFRA.BO) Income Statement Analysis – Financial Results
- Bowlin Travel Centers, Inc. (BWTL) Income Statement Analysis – Financial Results
- AP Memory Technology Corporation (6531.TW) Income Statement Analysis – Financial Results
Acadia Healthcare Company, Inc. (ACHC)
About Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.93B | 2.61B | 2.31B | 2.09B | 3.11B | 3.01B | 2.84B | 2.81B | 1.79B | 1.00B | 713.41M | 407.46M | 221.37M | 62.10M |
| Cost of Revenue | 2.25B | 1.49B | 1.33B | 1.24B | 1.84B | 1.78B | 1.65B | 1.66B | 1.05B | 623.83M | 445.53M | 259.14M | 167.94M | 42.36M |
| Gross Profit | 682.61M | 1.12B | 979.89M | 848.17M | 1.27B | 1.23B | 1.19B | 1.15B | 740.10M | 380.77M | 267.88M | 148.33M | 53.44M | 19.74M |
| Gross Profit Ratio | 23.31% | 42.78% | 42.34% | 40.58% | 40.78% | 40.96% | 41.80% | 40.97% | 41.24% | 37.90% | 37.55% | 36.40% | 24.14% | 31.79% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 176.01M | 203.48M | 175.26M | 157.85M | 323.21M | 307.71M | 273.00M | 258.83M | 148.99M | 64.68M | 47.22M | 26.86M | 57.74M | 3.08M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 176.01M | 203.48M | 175.26M | 157.85M | 323.21M | 307.71M | 273.00M | 258.83M | 148.99M | 64.68M | 47.22M | 26.86M | 57.74M | 3.08M |
| Other Expenses | 0.00 | 445.60M | 390.16M | 357.53M | 539.48M | -34.51M | -24.27M | -48.32M | -36.57M | -13.65M | -7.15M | -8.11M | 24.76M | -918.00K |
| Operating Expenses | 176.01M | 649.07M | 565.41M | 515.38M | 862.69M | 821.04M | 747.84M | 706.49M | 419.29M | 208.00M | 144.88M | 77.62M | 82.50M | 10.93M |
| Cost & Expenses | 2.42B | 2.14B | 1.90B | 1.76B | 2.70B | 2.60B | 2.40B | 2.37B | 1.47B | 831.84M | 590.41M | 336.75M | 250.44M | 53.29M |
| Interest Income | 0.00 | 69.76M | 76.99M | 158.11M | 187.33M | 876.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 82.13M | 69.76M | 76.99M | 158.11M | 187.09M | 185.41M | 176.01M | 181.33M | 106.74M | 48.22M | 37.25M | 29.77M | 9.19M | 738.00K |
| Depreciation & Amortization | 132.35M | 117.77M | 106.72M | 95.26M | 87.92M | 158.83M | 143.01M | 135.10M | 63.55M | 32.67M | 17.09M | 7.98M | 4.29M | 976.00K |
| EBITDA | 189.11M | 561.67M | 459.47M | 437.16M | 402.02M | 385.88M | 580.89M | 580.25M | 384.36M | 205.43M | 140.09M | 70.58M | -24.78M | 8.87M |
| EBITDA Ratio | 6.46% | 21.52% | 22.52% | 22.05% | 18.30% | 18.97% | 20.48% | 20.64% | 21.42% | 20.45% | 19.64% | 19.31% | -11.19% | 14.29% |
| Operating Income | 506.60M | 443.90M | 414.47M | 365.61M | 404.53M | 412.74M | 437.88M | 445.14M | 320.81M | 172.76M | 123.00M | 70.71M | -29.07M | 8.81M |
| Operating Income Ratio | 17.30% | 17.01% | 17.91% | 17.49% | 13.02% | 13.70% | 15.44% | 15.84% | 17.88% | 17.20% | 17.24% | 17.35% | -13.13% | 14.19% |
| Total Other Income/Expenses | -531.96M | -72.10M | -120.81M | -148.99M | -235.70M | -581.70M | -201.08M | -412.19M | -156.06M | -46.61M | -53.75M | -37.88M | -5.38M | -1.66M |
| Income Before Tax | -25.36M | 374.14M | 275.76M | 183.80M | 135.99M | -168.95M | 236.80M | 32.96M | 164.75M | 126.15M | 69.25M | 32.83M | -38.26M | 7.16M |
| Income Before Tax Ratio | -0.87% | 14.33% | 11.91% | 8.79% | 4.38% | -5.61% | 8.35% | 1.17% | 9.18% | 12.56% | 9.71% | 8.06% | -17.28% | 11.53% |
| Income Tax Expense | -9.70M | 94.11M | 67.56M | 40.61M | 25.87M | 6.53M | 37.21M | 28.78M | 46.40M | 42.92M | 25.98M | 12.33M | -5.38M | 477.00K |
| Net Income | -21.67M | 273.14M | 190.64M | 143.19M | 108.92M | -175.75M | 199.84M | 6.14M | 119.55M | 83.04M | 42.58M | 20.40M | -34.89M | 6.21M |
| Net Income Ratio | -0.74% | 10.46% | 8.24% | 6.85% | 3.51% | -5.83% | 7.05% | 0.22% | 6.66% | 8.27% | 5.97% | 5.01% | -15.76% | 10.00% |
| EPS | -0.24 | 3.05 | 2.30 | 1.63 | 1.24 | -2.01 | 2.30 | 0.07 | 1.75 | 1.51 | 0.85 | 0.53 | -1.86 | 0.35 |
| EPS Diluted | -0.24 | 2.98 | 2.25 | 1.62 | 1.24 | -2.01 | 2.30 | 0.07 | 1.75 | 1.50 | 0.85 | 0.53 | -1.86 | 0.35 |
| Weighted Avg Shares Out | 90.95M | 89.68M | 88.77M | 87.88M | 87.61M | 87.29M | 86.95M | 85.70M | 68.09M | 55.06M | 50.00M | 38.48M | 18.76M | 17.63M |
| Weighted Avg Shares Out (Dil) | 90.95M | 91.56M | 90.79M | 88.60M | 87.82M | 87.29M | 87.06M | 85.97M | 68.39M | 55.33M | 50.26M | 38.70M | 18.76M | 17.63M |
The Schall Law Firm Encourages Stockholder Contributions To A Securities Fraud Case Against Acadia Healthcare Company Inc
LOS ANGELES, CA / ACCESSWIRE / December 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of...
ACHC DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Acadia Healthcare Company, Inc. Investors of Deadline and Encourages Investors with Losses to Contact the Firm
RADNOR, Pa., Dec. 05, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Middle District...
ACHC Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Acadia Healthcare Company, Inc.
RADNOR, Pa. , Dec. 5, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare") (NASDAQ: ACHC) on behalf of...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Acadia Healthcare Company, Inc. - ACHC
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC). Such investors are advised to contact Danielle Peyton at...
Acadia Healthcare (ACHC) Faces SEC Subpoena Over Admissions and Billings Practices, Stock Falls Again, Class Action Pending – Hagens Berman
SAN FRANCISCO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Acadia Healthcare Company (NASDAQ: ACHC) is under fire as it faces a series of securities class-action lawsuits. Investors allege the company misled them about its business practices, with the most recent lawsuit,...
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Acadia Healthcare
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Acadia Healthcare To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Acadia Healthcare between February 28,...
ACHC CLASS UPDATE: The December 16 Investor Deadline in the Acadia Healthcare Securities Fraud Class Action is Approaching - Contact BFA Law if You have Losses
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ:ACHC) and certain of the Company's senior executives. If...
ACHC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Acadia Healthcare Company, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / December 5, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the...
ACADIA HEALTHCARE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Acadia Healthcare Company, Inc. - ACHC
NEW ORLEANS, Dec. 04, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 16, 2024 to file lead plaintiff applications in a securities class action lawsuit against Acadia Healthcare Company, Inc. (NasdaqGS:...
ACADIA HEALTHCARE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Acadia Healthcare Company, Inc. and Encourages Investors to Contact the Firm
NEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. (“Acadia Healthcare” or the “Company”) (NASDAQ:...
Source: https://incomestatements.info
Category: Stock Reports